company background image
SUNPHARMA

Sun Pharmaceutical Industries NSEI:SUNPHARMA Stock Report

Last Price

₹1.05k

Market Cap

₹2.5t

7D

0.2%

1Y

26.0%

Updated

30 Jan, 2023

Data

Company Financials +

Sun Pharmaceutical Industries Limited

NSEI:SUNPHARMA Stock Report

Mkt Cap: ₹2.5t

SUNPHARMA Stock Overview

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally.

SUNPHARMA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance1/6
Financial Health6/6
Dividends3/6

My Notes

New

Notes are coming soon

Sun Pharmaceutical Industries Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sun Pharmaceutical Industries
Historical stock prices
Current Share Price₹1,051.70
52 Week High₹1,070.95
52 Week Low₹789.90
Beta0.40
1 Month Change5.02%
3 Month Change1.46%
1 Year Change26.03%
3 Year Change151.87%
5 Year Change88.66%
Change since IPO51,634.03%

Recent News & Updates

Recent updates

These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well

Does This Valuation Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Imply Investors Are Overpaying?

Oct 13
Does This Valuation Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Imply Investors Are Overpaying?

These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Safely

Sep 04
These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Safely

Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's

Aug 05
Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's

Estimating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

Jul 12
Estimating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

Does Sun Pharmaceutical Industries (NSE:SUNPHARMA) Have A Healthy Balance Sheet?

Jun 02
Does Sun Pharmaceutical Industries (NSE:SUNPHARMA) Have A Healthy Balance Sheet?

Is Now The Time To Put Sun Pharmaceutical Industries (NSE:SUNPHARMA) On Your Watchlist?

Apr 28
Is Now The Time To Put Sun Pharmaceutical Industries (NSE:SUNPHARMA) On Your Watchlist?

Are Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Investors Paying Above The Intrinsic Value?

Apr 09
Are Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Investors Paying Above The Intrinsic Value?

Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Increasing Its Dividend To ₹7.00

Feb 02
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Increasing Its Dividend To ₹7.00

Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) Using Too Much Debt?

Feb 02
Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) Using Too Much Debt?

Should You Be Adding Sun Pharmaceutical Industries (NSE:SUNPHARMA) To Your Watchlist Today?

Jan 19
Should You Be Adding Sun Pharmaceutical Industries (NSE:SUNPHARMA) To Your Watchlist Today?

Estimating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

Dec 27
Estimating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

Sun Pharmaceutical Industries (NSE:SUNPHARMA) Seems To Use Debt Rather Sparingly

Nov 04
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Seems To Use Debt Rather Sparingly

Here's Why I Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Might Deserve Your Attention Today

Oct 21
Here's Why I Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Might Deserve Your Attention Today

Calculating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

Sep 27
Calculating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

This Is Why Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) CEO Can Expect A Bump Up In Their Pay Packet

Aug 24
This Is Why Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) CEO Can Expect A Bump Up In Their Pay Packet

Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹2.00

Aug 06
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹2.00

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Shares Could Be 23% Above Their Intrinsic Value Estimate

May 31
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Shares Could Be 23% Above Their Intrinsic Value Estimate

What Type Of Shareholders Make Up Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) Share Registry?

Mar 08
What Type Of Shareholders Make Up Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) Share Registry?

How Does Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Fare As A Dividend Stock?

Feb 22
How Does Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Fare As A Dividend Stock?

Interested In Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming ₹5.50 Dividend? You Have Three Days Left

Feb 04
Interested In Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming ₹5.50 Dividend? You Have Three Days Left

Sun Pharmaceutical Industries Limited Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

Feb 01
Sun Pharmaceutical Industries Limited Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Jan 20
Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

Jan 05
Don't Ignore The Fact That This Insider Just Sold Some Shares In Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well

Dec 28
These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well

Have Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Insiders Been Selling Their Stock?

Dec 12
Have Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Insiders Been Selling Their Stock?

Do Insiders Own Lots Of Shares In Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)?

Dec 07
Do Insiders Own Lots Of Shares In Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)?

Here's Why We Think Sun Pharmaceutical Industries's (NSE:SUNPHARMA) Statutory Earnings Might Be Conservative

Nov 22
Here's Why We Think Sun Pharmaceutical Industries's (NSE:SUNPHARMA) Statutory Earnings Might Be Conservative

Shareholder Returns

SUNPHARMAIN PharmaceuticalsIN Market
7D0.2%-1.3%-3.8%
1Y26.0%-4.1%-0.05%

Return vs Industry: SUNPHARMA exceeded the Indian Pharmaceuticals industry which returned -4.1% over the past year.

Return vs Market: SUNPHARMA exceeded the Indian Market which returned -0% over the past year.

Price Volatility

Is SUNPHARMA's price volatile compared to industry and market?
SUNPHARMA volatility
SUNPHARMA Average Weekly Movement2.2%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement5.6%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market3.3%

Stable Share Price: SUNPHARMA is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: SUNPHARMA's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198338,000Dilip Shanghvihttps://www.sunpharma.com

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products.

Sun Pharmaceutical Industries Limited Fundamentals Summary

How do Sun Pharmaceutical Industries's earnings and revenue compare to its market cap?
SUNPHARMA fundamental statistics
Market Cap₹2.50t
Earnings (TTM)₹41.05b
Revenue (TTM)₹410.24b

61.5x

P/E Ratio

6.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SUNPHARMA income statement (TTM)
Revenue₹410.24b
Cost of Revenue₹113.13b
Gross Profit₹297.11b
Other Expenses₹256.06b
Earnings₹41.05b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Jan 31, 2023

Earnings per share (EPS)17.11
Gross Margin72.42%
Net Profit Margin10.01%
Debt/Equity Ratio6.8%

How did SUNPHARMA perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

73%

Payout Ratio